Histone cluster 1 H2AD Inhibitors represent a specialized category of chemical compounds designed to selectively impede the activity of histone cluster 1, specifically targeting the H2AD subtype. Histones play a fundamental role in the organization and packaging of DNA within the nucleus, forming nucleosomes that contribute to chromatin structure. H2AD denotes a variant of histone H2A, one of the core histones responsible for nucleosome formation. The H2A family of histones is central to the regulation of gene expression and the modulation of chromatin architecture. Inhibitors developed for Histone cluster 1 H2AD are intricately designed to interact with specific regions of this histone variant, potentially influencing its binding to DNA and other proteins, thereby modulating chromatin dynamics.
To craft Histone cluster 1 H2AD Inhibitors, researchers delve into the detailed structural characteristics of histone H2AD and its precise role within chromatin organization. These inhibitors are engineered for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2AD and disrupt its normal functions. By employing these inhibitors in experimental settings, scientists can explore the consequences of inhibiting this specific histone variant, unraveling insights into chromatin remodeling and gene regulation. The study of histones, including their variants like H2AD, contributes significantly to our understanding of epigenetic mechanisms, offering critical insights into the dynamic processes governing gene expression and the intricate regulation of cellular functions at the chromatin level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat inhibits histone deacetylase, impacting chromatin structure and potentially affecting the acetylation status of histones, including H2AD. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a histone deacetylase inhibitor, altering chromatin structure and potentially affecting the acetylation status of histones, including H2AD. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2AD. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $179.00 $700.00 | 9 | |
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2AD. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966 inhibits histone deacetylase, altering chromatin structure and potentially modulating the transcription of genes, including Histone cluster 1 H2AD. | ||||||